Dr. Sarit Assouline
April 2024Milestones

Dr. Sarit Assouline appointed JGH Chief of Hematology

Dr. Sarit Assouline is the new Chief of Hematology, following the retirement of Dr. Hans Knecht after 10 years as Chief.

READ MORE →
Dr. Nathalie Johnson
Research at the Lady Davis InstituteSeptember 2022

Probing the benefits of exercise for patients and survivors of lymphoma

Although exercise is recognized as being good for cancer patients, hematologist Dr. Nathalie Johnson is taking a closer look at how it helps those with lymphoma.

READ MORE →
Dr. Sarit Assouline
May 2017Research at the Lady Davis Institute

Promising therapy for relapsed patients with aggressive form of lymphoma

A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.

READ MORE →